Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...

Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...

The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s ...

Late Friday evening, President-elect Donald Trump announced a slew of intended nominations for his administration, including ...

First-of-its-kind data analysis finds UnitedHealth Group pays many of its own physician practices significantly more than the ...

Join clinical experts as they address treatment challenges for breast cancer patients & explore the latest advancements at ...

The U.S. life sciences community is bracing for the return of travel restrictions in the second Trump administration.

Good morning, everyone, and welcome to another working week. We hope the weekend respite was enjoyable and invigorating, ...

The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

Health officials in California have discovered bird flu virus in raw milk for sale in a store in the state, a development ...

Opinion: RFK Jr. should look to what his uncle might have done: a large-scale public health program meeting people where they ...

Martin Makary, President-elect Trump’s pick for running the Food and Drug Administration, is an executive of the telehealth ...